IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection.
Villegas C, Poza M, Talayero P, Teller JMC, Zafra D, Garcia C, Vera E, Hidalgo M, Lopez N, Cuellar C, Zamanillo I, Íñiguez R, Paz-Artal E, Aguado JM, Martinez-Lopez J.
Villegas C, et al. Among authors: aguado jm.
Ann Hematol. 2020 Dec;99(12):2953-2956. doi: 10.1007/s00277-020-04160-w. Epub 2020 Jun 25.
Ann Hematol. 2020.
PMID: 32583087
Free PMC article.
No abstract available.